SEC Form D · filed October 2, 2023
NurExone Biologic Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Lior Shaltiel · Bnei-Brak, L3Exec · DirectorYoram 4. Drucker · Bnei-Brak, L3DirectorOded 4. Orgil · Bnei-Brak, L3DirectorEran Ovadya · Bnei-Brak, L3ExecGadi Riesenfeld · Bnei-Brak, L3DirectorJames 4. Richardson · Bnei-Brak, L3DirectorLior Shaltiel · Bnei-Brak, L3Exec · DirectorEran Ovadya · Bnei-Brak, L3ExecGadi Riesenfeld · Bnei-Brak, L3DirectorJames 4. Richardson · Bnei-Brak, L3DirectorOded 4. Orgil · Bnei-Brak, L3DirectorYoram 4. Drucker · Bnei-Brak, L3DirectorJoseph K. Fuqua · VANCOUVER, British Columbia, CanadaDirectorAnton F. Klaveness · VANCOUVER, British Columbia, CanadaDirectorMichael K. Mckenna · VANCOUVER, British Columbia, CanadaExec · DirectorMichael F. Westlake · VANCOUVER, British Columbia, CanadaExecScott Taylor · VANCOUVER, British Columbia, CanadaDirectorChristopher K. Green · VANCOUVER, British Columbia, CanadaDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗